FILTER
FILTERED INTERVIEW RESULTS
Enoch Kusi-Yeboah
GENERAL MANAGER, METSO MINERALS GHANA
From its offices in Ghana, Metso comments on how its offering is developing alongside the West African mining industry.
Enrique Garay
SENIOR VICE PRESIDENT, RIO2 LIMITED
The team from Rio Alto attempt to replicate its success with Rio2, beginning with Rio2’s Fenix Gold project.
Mark Venning
REGIONAL MINING LEADER, SOUTH AMERICA, STANTEC
Stantec comments on the current situation facing the EPCM market in Chile.
Chris Taylor
PRESIDENT & CEO, GREAT BEAR RESOURCES
Great Bear Resources represents a rare instance of a junior that is currently flourishing with significant gold descoveries.
Don Bubar
PRESIDENT AND CEO, AVALON ADVANCED MATERIALS
Avalon Advanced Materials is a mineral development company focused on rare metals and critical minerals for use in clean energy and new technologies.
Hugo Salamanca
PRESIDENT, HIGHSERVICE CORP.
HighService Corp. explains its recent partnership with Metso and speaks of the application of robotics in mining.
Marc Lauzier
GENERAL MANAGER - PORCUPINE GOLD MINES, NEWMONT
"Through the use of electric vehicles, we will be able to reduce 7,000 mt of greenhouse gas emissions and associated maintenance costs, as well as save the consumption of two million liters of diesel and one million liters of propane."
Guillermo Crevatin
GENERAL MANAGER CHILE, BOLIVIA AND PERU, MICHELIN
Michelin Chile speaks of the advantages of its acquisition of Fenner and how it is developing its offering for the mining industry.
Edgardo Orderique
GENERAL MANAGER – OPERATIONS, MMG-LAS BAMBAS
MMG-Las Bambas discusses operational improvements, tailings management, and plans for the future.
Christina Visser
GENERAL MANAGER, BLACK ROCK ENGINEERING
Black Rock Engineering is an engineering consulting company based in Sudbury, Ontario.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
